Owner Bayer Pharmaceuticals Corporation

Inventors WOOD, Jill E.; RIEDL, Bernd; SIBLEY, Robert; NATERO, Reina; SCOTT, William J.; KHIRE, Uday; RENICK, Joel; LOWINGER, Timothy B.; SMITH, Roger A.; MONAHAN, Mary-Katherine; DUMAS, Jacques

Agent Davies Collison Cave

Pub. Number AU-B-2004200566

Parent 27250

Filing date 13 February 2004

Wipo publication date 11 March 2004

Acceptance publication date 17 August 2006

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61K 31/34 (2006.01) - having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/50 (2006.01) - Pyridazines